The speaker of South Korea's National Assembly called for an investigation into martial law.The number of second-hand houses in Shenzhen was the highest in a single week in more than three years. It was learned from Shenzhen Real Estate Agency Association that in the 49th week of 2024 (December 2 -8), 2,390 sets of second-hand houses (including self-service) were recorded in the city, an increase of 12.6% from the previous month. The volume of second-hand houses recorded in a single week hit a new high in the past 200 weeks. (Shenzhen Special Zone Daily)The concept of humanoid robot fell by more than 10%, Sanfeng Intelligent fell by more than 10%, Eft and Wuzhou Spring fell by more than 8%, and many stocks such as Beite Technology, Mingzhi Electric and Shuanglin fell by more than 5%.
China made more than half of the imported cars registered in South Korea in November. According to a data released by CARISYOU, a Korean automobile data research institution, the proportion of Chinese-made cars registered in South Korea in November was 54.3%, setting a record this year. The data shows that there were 659 newly registered imported cars in November, of which 358 were made in China, accounting for 54.3%, setting a record for the highest proportion in a single month this year. By brand, BYD increased by 21.7% year-on-year to 140 vehicles, ranking first among all imported car brands. Brands such as Geely (No.3), Xinyuan (No.4), Haig School Bus (No.8) and Dongfeng Xiaokang (No.10) are also among the top ten. The number and proportion of Chinese-made cars registered in Hanxin increased year by year, with only 296 (6.2%) in 2020, 569 (9.9%) in 2021, 2276 (29%) in 2022 and 4215 (47.5%) in 2023.South Korean banks' net household loans increased by 1.9 trillion won in October.The concept of consumer electronics fluctuated higher than the daily limit of Tianjian and Yingtong Communication, while Tianjian and Yingtong Communication fluctuated higher than the daily limit. Zhongke Lanxun rose more than 8%, followed by Rambler, Guoguang Electric, hivi Technology and Zhuoyi Technology.
A court in Hong Kong dismissed the liquidation case against Territorial Holdings, and a court in Hong Kong dismissed the liquidation case after the petition against Territorial Holdings, a real estate developer in China, was revoked. Our headquarters finance group withdrew the petition, and the debts and expenses have been settled. The liquidation petition was filed in September, involving an outstanding sum of HK$ 275,633.29. (Interface News)Argentine President Millay: Negotiations on a free trade agreement with the Trump administration will be launched next year. Argentine President Millay said in a national televised speech on December 10 local time that he plans to negotiate a free trade agreement with the newly appointed Trump administration of the United States next year, and promised to make Argentina more independent from MERCOSUR. After the historic trade agreement between MERCOSUR and the European Union last week, he criticized that MERCOSUR has become a "prison" for member States. "Our ultimate goal in MERCOSUR is to improve the autonomy of the members of this group to the rest of the world." Millay said, "In this spirit, our primary goal will be to start a free trade agreement with the United States next year." He also mentioned on the same day that Argentina plans to cancel capital controls next year.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.
Strategy guide
12-13
Strategy guide
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13